Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zilucoplan in ALS (HEALEY Platform Regimen A)
NCT04436497Phase 3Completed
- Start
- Jul 2020
- Primary completion
- Apr 2022
- Modality
- Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of zilucoplan in amyotrophic lateral sclerosis (ALS). Started Jul 2020; status: completed.
02
Drugs
zilucoplan
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT04436497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04436497.